Thursday, January 31, 2013

• BioLineRx to Present at the 2013 BIO CEO & Investor Conference in New York on February 12thBusiness Wire (Thu, Jan 31)

Tuesday, January 15, 2013

• BioLineRx: Upcoming Catalyst With Potential Multi Billion-Dollar Schizophrenia Drugat Seeking Alpha (Tue, Jan 15)

Monday, January 7, 2013

• BioLineRx to Announce Interim Results of Phase II/III Trial for Schizophrenia Drug During Week of March 18, 2013Business Wire (Mon, Jan 7)

Thursday, December 6, 2012

• BioLineRx: Israeli Biotech Incubator With Multiple Near-Term Clinical Catalystsat Seeking Alpha (Thu, Dec 6)

Monday, December 3, 2012

• BioLine Is Approaching Its Moment Of Truthat Seeking Alpha (Mon, Dec 3)

Friday, November 30, 2012

• BioLineRx to Present at the 2012 Fifth Annual LD MICRO Conference in Los Angeles on December 5thBusiness Wire (Fri, Nov 30)

Wednesday, November 14, 2012

• BioLineRx Reports Third Quarter 2012 Financial ResultsBusiness Wire (Wed, Nov 14)

Monday, November 12, 2012

• BioLineRx to Hold Analyst and Investor Day in New York on December 4, 2012Business Wire (Mon, Nov 12)

Wednesday, November 7, 2012

• BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual MeetingBusiness Wire (Wed, Nov 7)

Monday, November 5, 2012

• BioLineRx to Report Third Quarter 2012 Results on November 14, 2012Business Wire (Mon, Nov 5)

Thursday, November 1, 2012

• A Capital-Efficient Prescription For New Drugs: Raghuram "Ram" Selvarajuat Seeking Alpha (Thu, Nov 1)

Wednesday, October 17, 2012

• A New And Interesting Addition To The Hep C Clinical Pipelineat Seeking Alpha (Wed, Oct 17)

Tuesday, October 2, 2012

• Kraft Foods Initiated at Buy and 4 Analyst-Initiated Shares on the Moveat Wall St. Cheat Sheet (Tue, Oct 2)

Thursday, September 27, 2012

• BioLineRx enters into share purchase agreement with Lincoln Park Capitaltheflyonthewall.com (Thu, Sep 27)

Tuesday, September 25, 2012

• Healthcare Business Recap: Peregrine Evaporates, BioLineRx’s New Patentat Wall St. Cheat Sheet (Tue, Sep 25)

Wednesday, September 5, 2012

• BiolineRx Enters The Oncology Field With In-Licensing Dealat Seeking Alpha (Wed, Sep 5)

Thursday, August 16, 2012

• Is The Hep C Drug Pipeline Beginning To Crack?at Seeking Alpha (Thu, Aug 16)

Wednesday, July 25, 2012

• Undervalued Biotech Stocks In Non-U.S. Markets: Part 1at Seeking Alpha (Wed, Jul 25)

Friday, July 20, 2012

• Healthcare Business Review: Vivus DISSED By Citron, Lundbeck, et al Have OPPORTUNITYat Wall St. Cheat Sheet (Fri, Jul 20)

Thursday, July 19, 2012

• The Race For The Next Blockbuster Schizophrenia Drugat Seeking Alpha (Thu, Jul 19)

Thursday, July 5, 2012

• BioLineRx: Upside Greater Than Stated By Analystat Seeking Alpha (Thu, Jul 5)

Tuesday, July 3, 2012

• BioLineRx initiated with a Buy at Roth Capitalat theflyonthewall.com (Tue, Jul 3)

Thursday, June 21, 2012

• BioLineRx: An Israeli Biotech Incubatorat Seeking Alpha (Thu, Jun 21)

Tuesday, January 24, 2012

• Stocks on the Move Nowat CNBC (Tue, Jan 24)

Add BLRX News to My Yahoo!